Our bioprognostic tests use proprietary sample collection methods, reproducible and precise measurement of senescence biomarkers, and multi-analyte algorithms to predict clinically meaningful, actionable health outcomes.
Proprietary sample collection technology to preserve immune components in whole blood for shipping
Assay development and rigorous analytical testing to clinical standards
Biostatistical and machine learning model development in prospective clinical studies
Risk report development based on clinical needs and actionability
Sapere Bio has the expertise and technology to bring senescence measurement to the clinic
We are the sole source of clinical senescence measurement with the analytical precision, quality assurance, proprietary blood preservation technology, and clinical context required for patient care.
A broad portfolio of studies fuels discovery
Close collaborations with leading physician scientists lay the scientific foundation for understanding how senescent cell load can be measured and modified to improve clinical outcomes.
Clinical need drives product development
Our commercial team conducts extensive market research to define opportunities where senescence measurement can be both actionable and of benefit to a large number of patients.
Our tests are optimized to integrate seamlessly into clinical work flow converting a 'simple' send-out blood test into essential clinical knowledge.
Leading clinical programs are cardiovascular and oncology.